After completing training in vascular and critical care neurology at Harvard, Dr. Kevin Sheth is the founding Chief of the Division of Neurocritical Care & Emergency Neurology and Associate Chair for Clinical Research at Yale. His interests are in the advancement of therapies for acute brain injury such as stroke, especially those complicated by brain ischemia, swelling and hemorrhage. In pioneering the development of new strategies to treat brain swelling, his work has changed the fundamental approach to brain injury in the ICU and catalyzed the creation of new technologies in drug delivery and neuroimaging. His research group uses clinical trials as a platform for discovery. In recent years, this platform has expanded to trials of prevention and recovery in brain injury. His group uses novel approaches to personalized medicine that also aid in identifying successful treatments. Under his leadership, Yale has served as a national model for academic critical care neurology units.

Dr. Sheth is the winner of the Robert Siekert Award from the American Heart Association (AHA) and the Derek Denny Brown Award from the American Neurological Association. His research has been funded by the NIH, American Academy of Neurology, AHA, and the US Army. He is the author of over 200 publications and has served on study sections for the NIH, AHA, FDA and NASA.

He has formed exciting partnerships with entrepreneurs, pharmaceutical companies, and medical device start-ups to bring forward highly innovative solutions. These efforts have resulted in extensive knowledge of FDA pathways, development of phase I-III drug programs, and implementation of new technology into the clinical workspace. His highly collaborative work is dedicated to the improved understanding of neurological disease in the critically ill. Dr. Sheth is committed to the care of his patients with acute brain injury.